- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care
Lilly study: 1 in 5 Alzheimer's patients misdiagnosed
May 20, 2013
J.K. WallThe study results, which will be released Monday afternoon, are part of Indianapolis-based Lilly’s campaign to get Medicare
to pay for use of its brain imaging agent Amyvid.
MoreCanada’s Supreme Court won’t hear Lilly appeal on Zyprexa
May 16, 2013
Bloomberg NewsEli Lilly claims recent decisions by Canadian courts invalidating 17 drug patents have made the country an outlier among major
developed countries.
MoreLechleiter's surgery to repair heart goes as planned
May 14, 2013
Bloomberg NewsEli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta
is functioning as intended, the Indianapolis-based drugmaker said.
MoreMichigan doctor named dean of IU School of Medicine
May 13, 2013
Associated PressDr. Jay Hess was picked to become the 10th dean in the school of medicine's 110-year history and the first dean in the past
five to come from outside IU.
MoreStudy rebuts hospitals' argument on Medicare, rising costs
May 13, 2013
Rather than raising prices on private health insurers to make up for inadequate payments from the government, hospitals across
the country have been raising prices just because they can, according to a new study.
MoreLilly stops development on cancer drug after failed study
May 10, 2013
Bloomberg NewsThe drug, enzastaurin, was in the most advanced stage of testing and had been expected to generate $260 million in annual
sales by 2018.
MoreWarner Transitional Services to close, lay off 112
May 8, 2013
IBJ StaffWarner relies on funds from the Indiana Family and Social Administration, but the FSSA recently decided to end that funding
after numerous complaints against the company went unresolved.
MoreIndiana firms lose ground on Fortune 500 list
May 7, 2013
Mason KingFive of the six Hoosier firms that appear in the 2013 rankings slipped from their positions in last year's list of the largest
U.S. companies.
MoreLilly CEO to step down temporarily due to surgery
May 6, 2013
J.K. WallJohn Lechleiter has been suffering from a dilated aorta, Eli Lilly and Co. said Monday. Current CFO Derica Rice will take
his place until later this summer.
MoreLilly's sales-force restructuring to affect 1,600-plus
May 6, 2013
J.K. WallLilly will eliminate 1,624 positions from its U.S. sales force in July, according to a notice the company made to state officials.
But some of those workers may be rehired by the firm.
MoreLilly taking hard look at Pfizer's new Viagra strategy
May 6, 2013
Associated PressMajor drugmakers, including Indianapolis-based Eli Lilly and Co., are closely watching Pfizer Inc.'s plan to sell Viagra directly
to consumers. The bold move blows up the drug industry's distribution model.
MoreNew seed fund aims to make Indiana a hotbed for digital health startups
May 4, 2013
J.K. WallInfuse Accelerator hopes to make early-stage investments in 12 to 15 companies a year.
MoreFeds scrutinize nursing home buying spree
April 27, 2013
J.K. WallIndiana’s county-owned hospitals have rushed to acquire nursing homes in the past two years, opening a revenue stream
for both the hospitals and the long-term-care facilities. But the additional federal revenue that has driven these purchases
could come under threat.
MoreAnti-smoking officials say Indiana funding cuts hurt
April 27, 2013
Associated PressA decision to cut state funding by 38 percent for programs that help people stop smoking and try to prevent others from starting
worries those behind the state's tobacco cessation efforts.
MoreLilly suing J&J for patent rights in Alzheimer's drug race
April 25, 2013
Bloomberg NewsEli Lilly and Co. is seeking to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay
availability of a potential treatment for Alzheimer’s disease.
MoreEli Lilly's profit shoots up despite lackluster sales
April 24, 2013
IBJ Staff and Associated PressThe Indianapolis pharmaceutical company left its full-year profit forecast unchanged despite a spike in first-quarter earnings.
Revenue fell short of analyst expectations.
MoreNora pharmacy recalls compounded drugs
April 23, 2013
Associated PressA pharmacy that makes specialty medications is recalling nearly 100 compounded drugs after federal regulators found potential
safety problems during an inspection.
MoreLilly on the rise as investors run back to pharma stocks
April 22, 2013
J.K. WallInvestors are gaining confidence in the ability of major drugmakers, including Eli Lilly and Co., to improve their pipelines
of new products. The big pharma firms begin to report first-quarter earnings this week.
MoreLilly's $30.6M tax abatement request clears hurdle
April 18, 2013
IBJ StaffThe pharmaceutical firm has $400 million in projects in the works for its facilities south of downtown. City officials have
advanced its request for tax breaks to a public hearing and final consideration May 1.
MoreHealth overhaul may grow Indiana addiction services
April 16, 2013
Associated PressThe possibility of thousands of Indiana residents becoming eligible for addiction treatment under the federal health overhaul
has state officials and providers preparing for an expansion.
MoreLilly seeks $30.6M in tax breaks on downtown projects
April 15, 2013
Mason KingIndianapolis development officials on Wednesday will weigh the 10-year requests from the pharmaceuticals giant related to
a new manufacturing plant and improvements to existing operations downtown.
MoreAnalysts: Lilly faces 'ugly' period until its pipeline produces
April 15, 2013
J.K. WallInvestor smiles about new experimental cancer drugs and an aggressive play for the animal health market in China turned to
frowns after Lilly disclosed deep cuts to its U.S. sales force.
MoreExpected revenue slump spurs Lilly to cut sales force
April 11, 2013
J.K. WallThe Indianapolis pharmaceuticals giant said Thursday that it would lay off hundreds of U.S. sales reps, as it prepares for
the loss of patent protection on two of its best-selling drugs.
MoreEmployer health coverage on 10-year fall, study says
April 11, 2013
Bloomberg NewsIndiana, Michigan and South Carolina saw the steepest declines in employer-backed coverage from 2000 to 2011, according to
a study released Thursday.
MoreTyco: No proof Lilly thieves used security report
April 8, 2013
Associated PressLawyers for a security company being sued in the theft of $60 million worth of pharmaceuticals from an Eli Lilly and Co. warehouse
in Connecticut say there's no proof the thieves used a report it prepared about security weaknesses in the building.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
these guys only skill was to steal from other's hard earned savings.
I voted for him last time and it WAS the LAST time. He needed to to quit running around the world on useless trips, and giving our $$ away to sports teams. I'll vote for anyone but Ballard next time. BTW...we gave $40M to the Pacers and cannot even watch the games on TV.
For the people concerned about traffic, you should know that mixed-use projects (like the one being proposed), actually allows for and encourages more people to walk and bike, thereby mitigating additional automobile traffic. If we continue to design and build suburban-type projects in the City (i.e. automobile-oriented projects), we are not offering anything different from what the suburbs offer, which means we will continue to lose jobs/people to the suburbs. The reason Broad Ripple is somewhat successful today is that people want to live in a place that offers the convenience of being able to walk/bike to restaurants, retail, nightlife, the Monon, etc. Why would you not want to support a project that is complimentary to what already makes the area desirable? The real argument with this project should be its lack-luster design and layout, not the density.
It is unfortunate that there is a perception that celebrities validate an event. The Indy 500 stands on its own, especially for those coming in from out of town. It was always so disturbing to read the gushing descriptions of Ashley Judd threaded throughout the local coverage. Very happy that era is at an end.
Good ole' Obamacare. Thanks liberals and those who didn't bother to vote.